argus

ALIVUS LIFE SCIENCES LIMITED

NSE: ALIVUSINE03Q20102417,414 Cr

Timeline

Time (IST)TypeMEventSrc
25 Aug, 02:33 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of Investor/Analyst meetingnse
18 Aug, 05:35 pmAlivus Life Sciences Limited has informed the Exchange regarding a press release dated August 18, 2026, titled "Alivus Life Sciences announces acquisition of majority stake in IQGenX.".nse
18 Aug, 05:33 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
18 Aug, 05:28 pmEnclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.nse
18 Aug, 05:24 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Acquisitionbse
11 Aug, 06:08 pmAlivus Life Sciences Limited has informed the Exchange regarding 'Business Responsibility & Sustainability Report for FY 2025-26'.nse
11 Aug, 05:53 pmAlivus Life Sciences Ltd - 543322 - Reg. 34 (1) Annual Report.bse
07 Aug, 12:25 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
07 Aug, 12:16 pmAlivus Life Sciences Limited has informed the Exchange about Transcript of earnings call held on July 31, 2026.nse
06 Aug, 03:13 pmAlivus Life Sciences Limited has informed the Exchange that Record date for the purpose of Dividend is 01-Sep-2026.nse
31 Jul, 11:58 amAlivus Life Sciences Limited has informed the Exchange about Link of Recordingnse
31 Jul, 11:44 amAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
30 Jul, 07:31 pmAlivus Life Sciences Limited has informed the Exchange regarding 'Allotment of Equity Shares under "Employee Stock Option Scheme, 2021"'.nse
30 Jul, 07:04 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
30 Jul, 07:04 pmAlivus Life Sciences Limited has informed the Exchange about Investor Presentationnse
30 Jul, 07:01 pmAlivus Life Sciences Limited has informed the Exchange regarding a press release dated July 30, 2026, titled "Press Release of the Company for the First Quarter ended June 30, 2026.".nse
30 Jul, 06:58 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Jul, 06:50 pmAlivus Life Sciences Ltd - 543322 - Unaudited Financial Results For The First Quarter Ended June 30, 2026.bse
30 Jul, 06:43 pmAlivus Life Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
30 Jul, 06:43 pmAlivus Life Sciences Ltd - 543322 - Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30, 2026bse
23 Jul, 04:20 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of meet - Earnings Callnse
23 Jul, 02:20 pmAlivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.bse
12 Jun, 07:25 pmprocedural0Nirma Limited submitted a copy of a disclosure under SEBI Takeover Regulations (Regulation 31(4)) to the stock exchange.nse
21 May, 03:23 pmAlivus Life Sciences Limited has informed the Exchange about Transcript of Earnings Call.nse
21 May, 03:21 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
20 May, 04:59 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.nse
19 May, 05:10 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of Investors/Analyst Meeting.nse
15 May, 02:25 pmAlivus Life Sciences Limited has informed the Exchange about Link of Earnings Call Recordingnse
15 May, 02:23 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
14 May, 08:08 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
14 May, 08:06 pmAlivus Life Sciences Limited has informed the Exchange about Investor Presentationnse
14 May, 08:00 pmAlivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
14 May, 07:59 pmAlivus Life Sciences Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Press Release of the Company for the fourth quarter and year ended March 31, 2026.".nse
14 May, 07:41 pmAlivus Life Sciences Ltd - 543322 - Board Meeting Outcome for Audited Financial Results And Recommendation Of Final Dividendbse
14 May, 07:40 pmAlivus Life Sciences Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2026, recommended Final Dividend of Rs. 5 per equity share.nse
14 May, 07:34 pmAlivus Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
14 May, 07:34 pmAlivus Life Sciences Ltd - 543322 - Audited Financial Results For The Quarter And Year Ended March 31, 2026bse
08 May, 12:57 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of meet - Earnings Call.nse
07 May, 07:24 pmAlivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Considering And Approving Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026 And To Consider And Recommend Dividend, If Any, On Equity Shares For The Year Ended March 31, 2026.bse
07 May, 06:47 pmAlivus Life Sciences Ltd - 543322 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
29 Apr, 05:09 pmAlivus Life Sciences Ltd - 543322 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure Abse
21 Mar, 12:52 pmAlivus Life Sciences Limited has informed the Exchange about General Updatesnse
21 Mar, 12:45 pmAlivus Life Sciences Ltd - 543322 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
12 Mar, 04:57 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of Analyst / Institutional Investor meeting.nse
06 Mar, 04:55 pmAlivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetingsnse
25 Feb, 07:51 pmAlivus Life Sciences Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI LODR '.nse
25 Feb, 07:47 pmAlivus Life Sciences Ltd - 543322 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')bse
16 Feb, 11:44 amAlivus Life Sciences Ltd - 543322 - Announcement Under Regulation 30 - Updatesbse
16 Feb, 11:43 amAlivus Life Sciences Limited has informed the Exchange about General Updatesnse
30 Jan, 06:44 pmAlivus Life Sciences Limited has informed the Exchange about Transcript of Earnings Callnse